Skip to main content
. 2022 Feb 11;25(4):123. doi: 10.3892/mmr.2022.12639

Figure 2.

Figure 2.

Knockdown of DDX11-AS1 enhances the sensitivity of drug-resistant breast cancer cells to PTX. Reverse transcription-quantitative PCR assay detected the expression levels of DDX11-AS1 in (A) MCF-7/PTX, (B) MDA-MB-231/PTX, (C) MCF-7 and (D) MDA-MB-231 cells after transfection. CCK-8 assay detected (E) cell viability and (F) cell inhibition rate in the MCF-7/PTX cell line. CCK-8 assay detected (G) cell viability and (H) cell inhibition rate in the MDA-MB-231/PTX cell line. ***P<0.001 vs. shRNA-NC. CCK-8, Cell Counting Kit-8; DDX11-AS1, DDX11 antisense 1; lncRNA, long non-coding RNA; NC, negative control; PTX, paclitaxel; shRNA, short hairpin RNA.